UNSPSC 51283406: Penicillin V or phenoxymethylpenicillin

This classification denotes a penicillin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z61I075U2W. European Medicines Agency schedules Penicillin v in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09779MIG. Penicillin v generally arises in the molecular formula C16H18N2O5S. The term 'penicillin v' is a European Pharmacopoeia designation. SMILES: S1C2N(C(C1(C)C)C(=O)O)C(=O)C2NC(=O)COC1CCCCC1.

UNSPSC 51283406 Penicillin V or phenoxymethylpenicillin is a Commodity code that does not reflect the pharmaceutical products actually being procured under the opportunities recently tagged to it. The recent state and local solicitations show naloxone, doxycycline hyclate, ciprofloxacin hydrochloride, and drug deactivation systems — none of which are penicillin V. The code sees minimal relevant activity in the sourced opportunities; the mismatch between the code's nominal scope and the goods being purchased suggests either tagging errors in the source data or that this code tier is not routinely used for state and local procurement in the current period.

The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 for doxycycline hyclate 100mg tablets and ciprofloxacin hydrochloride 500mg tablets through the MMCAP Infuse consortium, with a total award value of $2,999,999.11 over a 12-month initial term plus two renewal years. Seminole County, Florida issued an IFB on June 30, 2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford. Both opportunities reflect state and county health agencies purchasing antimicrobial agents and emergency-response pharmaceuticals, but neither aligns with the penicillin V commodity code designation. With no current open solicitations under the code's actual scope and a recent award history that diverges materially from the code name, pursuit interest should be limited unless procurement activity shifts to reflect the code's stated commodity.